The demand for precision cancer imaging in USA is projected to grow from USD 2.3 billion in 2025 to USD 4.3 billion by 2035, at a CAGR of 6.4%. Molecular Imaging will dominate with a 46.0% market share, while hospitals will lead the end user segment with a 58.4% share.